Risperdal Plaintiffs Push For Release Of J&J Studies

Law360, Philadelphia (December 11, 2013, 2:19 PM EST) -- Plaintiffs in a cluster of product liability lawsuits against a Johnson & Johnson unit over the antipsychotic drug Risperdal told a Pennsylvania judge on Tuesday that documents detailing the medication’s risks were too vital to the public interest to remain under seal as part of court proceedings.

In a brief, attorneys representing plaintiffs in nearly 275 product liability suits against Janssen Pharmaceuticals Inc. pending in the Philadelphia County Court of Common Pleas blasted a motion by the drugmaker looking to maintain a 2011 order protecting the...
To view the full article, register now.